Material Type

• Blood (whole) (1)
• Isolated peripheral blood mononuclear cells (viable) (2)
• Serum (2)
• Solid tissue (non viable) (1)
• Swab medium (2)
• Urine (random) (1)

Microscopic Assessment

• Affected (1)
• Not applicable (4)

Storage Temperature

• RT (1)
• -35°C to -18°C (2)
• -85°C to -60°C (3)
• Liquid nitrogen (2)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (2)
• Followup records (2)
• Freezer temperature logs (2)
• Imaging data (2)
• Microbiological results (2)
• Physiological/biochemical measurements (1)
• Pre-analytical data (2)
• Quality indicators (1)
• Survey data (4)
• Treatment records (2)

Timeframe

• Immediate (1)
• 0 - 3 months (5)
• 3 - 6 months (2)
• > 6 months (2)

Participant Count

• 11 - 100 (5)

Sex

• Both sexes (5)

Age Range

• Young child (2 - 6 years) (1)
• Child (6 - 12 years) (2)
• Adolescent (12 - 18 years) (2)
• Young adult (18 - 40 years) (3)
• Adult (> 40 years) (5)

Biobank Services

• Ability to recontact (1)
• Cell culture (2)
• Digital imaging (1)
• Immunohistochemistry - staining (1)
• Infectious strain isolation (2)
• Molecular Extractions (1)
• Nucleic acid extraction (5)

Collection Type

• Cohort (1)
• Cross-sectional (1)
• Disease specific (2)

Consent Restriction

• No Commercial restriction (3)
• No Disease area restriction (4)
• No Genetic analysis restriction (4)
• No Human genetic analysis restriction (3)
• No restrictions (1)
• No Project specific restriction (5)
• No Scope of use restriction (2)

Collection Status

• In progress (5)

Access Condition

• Open to applicants (1)
• Open in response to specific calls (1)
• Open only through collaboration (1)
• Access restricted at present (2)

Country

• Cameroon (1)
• Côte d'Ivoire (1)
• Germany (1)
• Spain (1)
• United States (1)

County